Kamada Ltd.
$7.87+3.55%(+$0.27)
TickerSpark Score
84/100
87
Valuation
80
Profitability
95
Growth
100
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KMDA research report →
52-Week Range48% of range
Low $6.50
Current $7.87
High $9.35
Companywww.kamada.com
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution.
- CEO
- Amir London
- IPO
- 2013
- Employees
- 420
- HQ
- Rehovot, IL
Price Chart
+14.56% · this period
Valuation
- Market Cap
- $453.99M
- P/E
- 22.40
- P/S
- 2.50
- P/B
- 1.69
- EV/EBITDA
- 10.28
- Div Yield
- 3.18%
Profitability
- Gross Margin
- 42.32%
- Op Margin
- 14.50%
- Net Margin
- 11.18%
- ROE
- 7.75%
- ROIC
- 6.79%
Growth & Income
- Revenue
- $195.34M · 21.37%
- Net Income
- $21.86M · 51.18%
- EPS
- $0.38 · 52.00%
- Op Income
- $28.40M
- FCF YoY
- -54.05%
Performance & Tape
- 52W High
- $9.35
- 52W Low
- $6.50
- 50D MA
- $8.33
- 200D MA
- $7.63
- Beta
- 0.89
- Avg Volume
- 62.63K
Get TickerSpark's AI analysis on KMDA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 25, 24 | Asher-Topilsky Lilach | other | 6,625 |
| Dec 22, 26 | Asher-Topilsky Lilach | other | 7,500 |
| Dec 22, 26 | Botzer Uri | other | 7,500 |
| Apr 7, 26 | Gorelik Boris | other | 3,750 |
| Apr 7, 26 | Gorelik Boris | sell | 3,750 |
| Apr 7, 26 | Reshef Liron | sell | 15,000 |
| Apr 7, 26 | Reshef Liron | other | 15,000 |
| Apr 7, 26 | Reshef Liron | other | 10,000 |
| Apr 7, 26 | Reshef Liron | sell | 10,000 |
| Apr 7, 26 | London Amir | sell | 100,000 |
Our KMDA Coverage
We haven't published any research on KMDA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KMDA Report →